CVS Health Corp reported better-than-expected earnings for Q3, with adjusted EPS of $2.21 (Est. $2.13) and sales of $89.76B (Est. $88.25B). The company's strong performance in the pharmacy segment contributed to the positive results. CVS's stock price dropped by 4.3% in pre-market trading. In another news, Shell ADR reported lower-than-expected earnings for Q3, with EPS of $0.93 (Est. $1.86) and revenue of $76.35B (Est. $83.75B). The company's market cap is currently valued at $218.94B.
💰 Shell ADR $SHEL EPS. vs Forecast 0.93 / 1.86 🔴 Rev. vs Forecast 76.35B / 83.75B 🔴 Market Cap: 218.94B - https://t.co/orvmA6Wqwk
CVS profit beats estimates on strong performance of pharmacy segment https://t.co/OuL4Hx7EaX https://t.co/IkSp6IDXje
$CVS (-4.3% pre) CVS Health earnings top forecasts on pharmacy, health care benefits strength https://t.co/NC6woqtBQ8
$CVS | CVS Health Q3 Earnings: - Adjusted EPS $2.21 (Est. $2.13) - Sales $89.76B (Est. $88.25B)
💰 CVS Health Corp $CVS EPS. vs Forecast 2.21 / 2.13 🟢 Rev. vs Forecast 89.76B / 88.29B 🟢 Market Cap: 88.64B - https://t.co/orvmA6Wqwk